Stopping Statins After 70 Raises Risk to 13%
Stopping Statins After 70 Raises Risk to 13%
Stopping Statins After 70 Raises Risk to 13%
Key points
اہم نکات
मुख्य बातें
- Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found.
- The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions.
- Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting.
- Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found.
- The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions.
- Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting.
- Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found.
- The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions.
- Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting.
Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found. The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions. Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting. There was no meaningful difference in quality of life, muscle pain or falls, and experts said the choice should be made with a doctor, not as a blanket rule.
Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found. The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions. Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting. There was no meaningful difference in quality of life, muscle pain or falls, and experts said the choice should be made with a doctor, not as a blanket rule.
Stopping statins raised the risk of a heart attack, stroke or death to 13% over four years, against 9% for older patients who kept taking them, a trial of 1,880 adults aged 70 and older found. The STREAM trial, presented on November 7 at the American Heart Association meeting in Chicago and published in The New England Journal of Medicine, followed people with no history of heart disease but at least two chronic conditions. Stopping looked safe over two years, but the gap grew with longer follow-up, and the trial's safety board advised those who stopped to talk to their doctors about restarting. There was no meaningful difference in quality of life, muscle pain or falls, and experts said the choice should be made with a doctor, not as a blanket rule.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।